181 related articles for article (PubMed ID: 11350874)
1. Biomarkers for early detection of colon cancer.
Srivastava S; Verma M; Henson DE
Clin Cancer Res; 2001 May; 7(5):1118-26. PubMed ID: 11350874
[TBL] [Abstract][Full Text] [Related]
2. Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials.
Einspahr JG; Alberts DS; Gapstur SM; Bostick RM; Emerson SS; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):37-48. PubMed ID: 8993796
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.
Kelloff GJ; Sigman CC; Johnson KM; Boone CW; Greenwald P; Crowell JA; Hawk ET; Doody LA
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):127-37. PubMed ID: 10698472
[TBL] [Abstract][Full Text] [Related]
4. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
5. Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial.
Kim YI; Baik HW; Fawaz K; Knox T; Lee YM; Norton R; Libby E; Mason JB
Am J Gastroenterol; 2001 Jan; 96(1):184-95. PubMed ID: 11197251
[TBL] [Abstract][Full Text] [Related]
6. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis.
Mori H; Yamada Y; Kuno T; Hirose Y
Mutat Res; 2004 May; 566(3):191-208. PubMed ID: 15082237
[TBL] [Abstract][Full Text] [Related]
7. Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer.
Chang H; Su JM; Huang CC; Liu LC; Tsai CH; Chou MC; Lin P
Cancer Detect Prev; 2005; 29(6):562-9. PubMed ID: 16289386
[TBL] [Abstract][Full Text] [Related]
8. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
Reddy BS
Environ Mol Mutagen; 2004; 44(1):26-35. PubMed ID: 15199544
[TBL] [Abstract][Full Text] [Related]
9. Aberrant crypt foci in colon cancer epidemiology.
Khare S; Chaudhary K; Bissonnette M; Carroll R
Methods Mol Biol; 2009; 472():373-86. PubMed ID: 19107443
[TBL] [Abstract][Full Text] [Related]
10. Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk.
Payne CM; Holubec H; Bernstein C; Bernstein H; Dvorak K; Green SB; Wilson M; Dall'Agnol M; Dvorakova B; Warneke J; Garewal H
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2066-75. PubMed ID: 16172211
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations.
Verma M; Manne U
Crit Rev Oncol Hematol; 2006 Oct; 60(1):9-18. PubMed ID: 16829121
[TBL] [Abstract][Full Text] [Related]
12. Modulation of DNA hypomethylation as a surrogate endpoint biomarker for chemoprevention of colon cancer.
Tao L; Wang W; Kramer PM; Lubet RA; Steele VE; Pereira MA
Mol Carcinog; 2004 Feb; 39(2):79-84. PubMed ID: 14750212
[TBL] [Abstract][Full Text] [Related]
13. Intermediate effect markers for colorectal cancer.
Baron JA
IARC Sci Publ; 2001; 154():113-29. PubMed ID: 11220651
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic biomarkers in hematological malignancies.
Bagg A; Cossman J
J Cell Biochem Suppl; 1996; 25():165-71. PubMed ID: 9027614
[TBL] [Abstract][Full Text] [Related]
15. Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci.
Ziliotto L; Barbisan LF; Rodrigues MA
Hum Exp Toxicol; 2008 Jun; 27(6):505-11. PubMed ID: 18784204
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in the colonic crypt, colorectal adenomata, and manipulation by chemoprevention.
West NJ; Courtney ED; Poullis AP; Leicester RJ
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1680-7. PubMed ID: 19505899
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology, clinical presentation, and management of colon cancer.
Cappell MS
Gastroenterol Clin North Am; 2008 Mar; 37(1):1-24, v. PubMed ID: 18313537
[TBL] [Abstract][Full Text] [Related]
18. Aberrant crypt foci.
Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
[TBL] [Abstract][Full Text] [Related]
19. Purified and endogenous phytic acid in wheat bran affects early biomarkers of colon cancer risk.
Jenab M; Thompson LU
IARC Sci Publ; 2002; 156():387-9. PubMed ID: 12484214
[No Abstract] [Full Text] [Related]
20. Targeted colon cancer screening: a concept whose time has almost come.
Lieberman DA
Am J Gastroenterol; 1992 Sep; 87(9):1085-93. PubMed ID: 1519564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
